{"transactions":[{"id":3200773,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":150451,"kind":"person","name":"Adelman Michael","position":1,"cik":"0001749435","reported_name":"Adelman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-19T22:33:29.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":134800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on February 17, 2021."}],"balance_after":134800,"derivative":{"exercise_price":0.498,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":134800},"source":{"system":"sec-edgar","filing":"0001019056-20-000239","document":"adelman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000239/adelman.xml","form_type":"4"}},{"id":3380358,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":150451,"kind":"person","name":"Adelman Michael","position":1,"cik":"0001749435","reported_name":"Adelman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-06T01:50:20.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":114247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on November 1, 2020, the one-year anniversary of the grant date."}],"balance_after":114247,"derivative":{"exercise_price":0.576,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":114247},"source":{"system":"sec-edgar","filing":"0001019056-19-000610","document":"adelman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000610/adelman.xml","form_type":"4"}},{"id":3619206,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":150451,"kind":"person","name":"Adelman Michael","position":1,"cik":"0001749435","reported_name":"Adelman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Restricted Stock Unit","published_at":"2019-03-05T02:03:07.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":7318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 1, 2016 the reporting person was granted 21,958 restricted stock units. 7,320 shares of common stock underlying the restricted stock units vested on each of March 1, 2017 and March 1, 2018, and the remaining 7,318 shares vested on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 1, 2016 the reporting person was granted 21,958 restricted stock units. 7,320 shares of common stock underlying the restricted stock units vested on each of March 1, 2017 and March 1, 2018, and the remaining 7,318 shares vested on March 1, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7318},"source":{"system":"sec-edgar","filing":"0001019056-19-000174","document":"adelman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000174/adelman.xml","form_type":"4"}},{"id":3619205,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":150451,"kind":"person","name":"Adelman Michael","position":1,"cik":"0001749435","reported_name":"Adelman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-05T02:03:07.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three approximately equal annual installments beginning on February 28, 2020."}],"balance_after":67400,"derivative":{"exercise_price":1.52,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-19-000174","document":"adelman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000174/adelman.xml","form_type":"4"}},{"id":3619204,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":150451,"kind":"person","name":"Adelman Michael","position":1,"cik":"0001749435","reported_name":"Adelman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2019-03-05T02:03:07.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":2395,"price":1.57,"value":3760.15,"ownership":{"direct":true},"balance_after":70426,"source":{"system":"sec-edgar","filing":"0001019056-19-000174","document":"adelman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000174/adelman.xml","form_type":"4"}},{"id":3619203,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":150451,"kind":"person","name":"Adelman Michael","position":1,"cik":"0001749435","reported_name":"Adelman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2019-03-05T02:03:07.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":7318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":72821,"source":{"system":"sec-edgar","filing":"0001019056-19-000174","document":"adelman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000174/adelman.xml","form_type":"4"}}]}